Dyne Therapeutics slides 9% on $375M marketed equity offering

DYN Dyne Therapeutics Inc

$16.37 +2.50%

View chart & analysis →

1. 1Dyne Therapeutics (DYN) shares dropped 9% on Wednesday.
2. 2The company expects to raise approximately $375.15 million through an upsized offering of 18.3 million common shares at $20.50 each, pricing about 14% below Tuesday's close of $23.83.
3. 3The offering is expected to close on or around July 23, with underwriters granted a 30-day option to purchase up to an additional 2.745 million shares; Morgan Stanley, Jefferies, and Evercore ISI are serving as joint book-running managers.

Source Investor's Business Daily +1 · View original ↗

Today's 5 AI picks, all free

Nothing hidden: past picks and how they did against the S&P 500.

See today's picks →